Esther Mondo
Experienced in Lung Adenocarcinoma

Dr. Esther Mondo

Hematology Oncology | Oncology
Banner Health
Banner MD Anderson Cancer Center In Loveland
2000 Boise Avenue, 
Loveland, CO 
Accepting New Patients

Experienced in Lung Adenocarcinoma
Banner Health
Banner MD Anderson Cancer Center In Loveland
2000 Boise Avenue, 
Loveland, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

book clubs, board games, camping, concerts.

Dr. Mondo is rated as an Experienced provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Thrombocytopenia, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Large-Cell Immunoblastic Lymphoma.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Jefferson Medical College, 2010
Residency
University of Rochester Oral/Maxillofacial Surgery, Internal Medicine, 2013
Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in CO
Board Certifications
American Board Of Internal Medicine/Medical Oncology
American Board Of Internal Medicine
American Board Of Internal Medicine/Hematology
Fellowships
University of Rochester School of Medicine, Hematology/Oncology, 2016
Hospital Affiliations
Banner North Colorado Medical Center - Loveland Campus
Sterling Regional MedCenter
Banner North Colorado Medical Center
Banner Ft Collins Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Banner MD Anderson Cancer Center in Loveland
2000 Boise Avenue, Loveland, CO 80538
Other Locations
Banner MD Anderson Cancer Center in Greeley
1801 16th Street, Greeley, CO 80631

Additional Areas of Focus

Dr. Mondo has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Breast Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
eMonarcHER: A Randomized, Double Blind, Placebo-Controlled Phase 3 Study of Abemaciclib Plus Standard Adjuvant Endocrine Therapy in Participants With High-Risk, Node-Positive, HR+, HER2+ Early Breast Cancer Who Have Completed Adjuvant HER2-Targeted Therapy
Enrollment Status: Terminated
Publish Date: July 15, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3
Atorvastatin in Triple-Negative Breast Cancer (TNBC) Patients Who Did Not Achieve a Pathologic Complete Response (pCR) After Receiving Neoadjuvant Chemotherapy, a Multicenter Pilot Study
Atorvastatin in Triple-Negative Breast Cancer (TNBC) Patients Who Did Not Achieve a Pathologic Complete Response (pCR) After Receiving Neoadjuvant Chemotherapy, a Multicenter Pilot Study
Enrollment Status: Terminated
Publish Date: October 02, 2024
Intervention Type: Drug
Study Drugs: Atorvastatin, Capecitabine
Study Phase: Phase 2
View 2 Less Clinical Trials

3 Total Publications

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
Journal: PloS one
Published: February 26, 2017
View All 3 Publications
Similar Doctors
Paul A. Bunn
Elite in Lung Adenocarcinoma
Dr. Paul A. Bunn
Oncology
Elite in Lung Adenocarcinoma
Dr. Paul A. Bunn
Oncology

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (47.0 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Paul Bunn is an Oncologist in Aurora, Colorado. Dr. Bunn is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and Endoscopy. Dr. Bunn is currently accepting new patients.

Elite in Lung Adenocarcinoma
Dr. Robert C. Doebele
Oncology
Elite in Lung Adenocarcinoma
Dr. Robert C. Doebele
Oncology
12605 E 16th Ave, 
Aurora, CO 
 (47.0 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances

Robert Doebele is an Oncologist in Aurora, Colorado. Dr. Doebele is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Lung Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

Elite in Lung Adenocarcinoma
Dr. David R. Camidge
Oncology
Elite in Lung Adenocarcinoma
Dr. David R. Camidge
Oncology

University Physicians Incorporated

13123 E 16th Ave, 
Aurora, CO 
 (47.0 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Camidge is an Oncologist in Aurora, Colorado. Dr. Camidge is rated as an Elite provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Tissue Biopsy. Dr. Camidge is currently accepting new patients.

VIEW MORE LUNG ADENOCARCINOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mondo's expertise for a condition
ConditionClose
    • Distinguished
    • Paget Disease of the Breast
      Dr. Mondo is
      Distinguished
      . Learn about Paget Disease of the Breast.
      See more Paget Disease of the Breast experts
    • Thrombocytopenia
      Dr. Mondo is
      Distinguished
      . Learn about Thrombocytopenia.
      See more Thrombocytopenia experts
    • Advanced
    • Adult Immune Thrombocytopenia
      Dr. Mondo is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Breast Cancer
      Dr. Mondo is
      Advanced
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Familial Pancreatic Cancer
      Dr. Mondo is
      Advanced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Glioma
      Dr. Mondo is
      Advanced
      . Learn about Glioma.
      See more Glioma experts
    • Hemangioma Thrombocytopenia Syndrome
      Dr. Mondo is
      Advanced
      . Learn about Hemangioma Thrombocytopenia Syndrome.
      See more Hemangioma Thrombocytopenia Syndrome experts
    • Immune Thrombocytopenic Purpura (ITP)
      Dr. Mondo is
      Advanced
      . Learn about Immune Thrombocytopenic Purpura (ITP).
      See more Immune Thrombocytopenic Purpura (ITP) experts
    View All 11 Advanced Conditions
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Mondo is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Mondo is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anal Cancer
      Dr. Mondo is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Anemia
      Dr. Mondo is
      Experienced
      . Learn about Anemia.
      See more Anemia experts
    • Angiosarcoma
      Dr. Mondo is
      Experienced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Antiphospholipid Syndrome
      Dr. Mondo is
      Experienced
      . Learn about Antiphospholipid Syndrome.
      See more Antiphospholipid Syndrome experts
    View All 77 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.